Kamboh, M. I., Minster, R. L., Kenney, M., Ozturk, A., Desai, P. P., Kammerer, C. M., & DeKosky, S. T. (2005). Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer’s disease.
Chicago Style CitationKamboh, M. Ilyas, Ryan L. Minster, Margaret Kenney, Ayla Ozturk, Purnima P. Desai, Candace M. Kammerer, i Steven T. DeKosky. Alpha-1-antichymotrypsin (ACT or SERPINA3) Polymorphism May Affect Age-at-onset and Disease Duration of Alzheimer’s Disease. 2005.
Cita MLAKamboh, M. Ilyas, et al. Alpha-1-antichymotrypsin (ACT or SERPINA3) Polymorphism May Affect Age-at-onset and Disease Duration of Alzheimer’s Disease. 2005.
Atenció: Aquestes cites poden no estar 100% correctes.